A two-compartment model of VEGF distribution in the mouse

• Published in: PloS one 2011-11, Vol.6 (11), p.e27514
• Main Authors: Yen, Phillip, Finley, Stacey D, Engel-Stefanini, Marianne O, Popel, Aleksander S
• Format: Article
• Language: English
• Subjects: Analysis; Angiogenesis; Angiogenesis Inhibitors; Angiogenic Proteins; Animal models; Animal tissues; Animals; Biology; Biomedical engineering; Blood; Cardiovascular disease; Cell adhesion & migration; Compartments; Computational neuroscience; Computer simulation; Data processing; Drug development; Endothelial cells; Endothelium; Engineering; Esophageal cancer; Experimental data; Extracellular matrix; Hypertension; In vivo methods and tests; Isoforms; Kinases; Macromolecules; Medicine; Mice; Microvasculature; Models, Biological; Mouse devices; Musculoskeletal system; Neuropilin; Neuropilin-1 - metabolism; Parameter estimation; Parameter sensitivity; Peptide Fragments - metabolism; Permeability; Protein Binding; Receptors; Rodents; Secretion; Sensitivity analysis; Simulation; Skeletal muscle; Studies; Tissue Distribution; Tissues; Tumors; Vascular endothelial growth factor; Vascular Endothelial Growth Factor A - metabolism; Vascular Endothelial Growth Factor Receptor-1 - metabolism; Vascular Endothelial Growth Factor Receptor-2 - metabolism; Vascular endothelial growth factor receptors
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0027514

Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis--the growth of new microvessels from existing microvasculature. Angiogenesis is a complex process involving numerous molecular species, and to better understand it, a systems biology approach is necessary. In vivo preclinical experiments in the area of angiogenesis are typically performed in mouse models; this includes drug development targeting VEGF. Thus, to quantitatively interpret such experimental results, a computational model of VEGF distribution in the mouse can be beneficial. In this paper, we present an in silico model of VEGF distribution in mice, determine model parameters from existing experimental data, conduct sensitivity analysis, and test the validity of the model. The multiscale model is comprised of two compartments: blood and tissue. The model accounts for interactions between two major VEGF isoforms (VEGF(120) and VEGF(164)) and their endothelial cell receptors VEGFR-1, VEGFR-2, and co-receptor neuropilin-1. Neuropilin-1 is also expressed on the surface of parenchymal cells. The model includes transcapillary macromolecular permeability, lymphatic transport, and macromolecular plasma clearance. Simulations predict that the concentration of unbound VEGF in the tissue is approximately 50-fold greater than in the blood. These concentrations are highly dependent on the VEGF secretion rate. Parameter estimation was performed to fit the simulation results to available experimental data, and permitted the estimation of VEGF secretion rate in healthy tissue, which is difficult to measure experimentally. The model can provide quantitative interpretation of preclinical animal data and may be used in conjunction with experimental studies in the development of pro- and anti-angiogenic agents. The model approximates the normal tissue as skeletal muscle and includes endothelial cells to represent the vasculature. As the VEGF system becomes better characterized in other tissues and cell types, the model can be expanded to include additional compartments and vascular elements.